Alnylam on Bioeconhttps://en.bioecon.ru/companies/alnylam/Recent content in Alnylam on BioeconHugoen-USSat, 11 Jul 2026 11:21:28 +0700Nucleic acid therapeutics (oligonucleotides)https://en.bioecon.ru/technology/nucleic-acid-therapeutics/Sat, 11 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/nucleic-acid-therapeutics/Short synthetic oligonucleotides — siRNA and antisense — bind a target messenger RNA to silence or reprogram a disease gene, enabled by GalNAc liver targeting and sugar/backbone chemistries, with multiple approved drugs across rare, neurological and cardiometabolic disease.